PortfoliosLab logoPortfoliosLab logo
EKG vs. IDNA
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

EKG vs. IDNA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in First Trust Nasdaq Lux Digital Health Solutions ETF (EKG) and iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, EKG achieves a -10.11% return, which is significantly lower than IDNA's 10.31% return.


EKG

1D
-0.20%
1M
2.98%
YTD
-10.11%
6M
-12.99%
1Y
-0.93%
3Y*
-0.66%
5Y*
10Y*

IDNA

1D
0.73%
1M
-2.56%
YTD
10.31%
6M
8.52%
1Y
40.87%
3Y*
6.74%
5Y*
-8.42%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

EKG vs. IDNA - Yearly Performance Comparison


2026 (YTD)2025202420232022
EKG
First Trust Nasdaq Lux Digital Health Solutions ETF
-10.11%11.89%6.53%-0.11%-19.59%
IDNA
iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund
10.31%17.26%-0.72%-7.63%-26.25%

Correlation

The correlation between EKG and IDNA is 0.58, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.58

Correlation (3Y)
Calculated over the trailing 3-year period

0.59

Correlation (All Time)
Calculated using the full available price history since Mar 24, 2022

0.67

The correlation between EKG and IDNA has been stable across timeframes, ranging from 0.58 to 0.67 - a consistent structural relationship.

EKG vs. IDNA - Sectors Allocation Comparison


Sectors
EKG
IDNA

Healthcare

94.9%
97.8%

Technology

2.6%

-

Basic Materials

-

-

Communication Services

-

-

Consumer Cyclical

-

-

Consumer Defensive

-

-

Energy

-

-

Financial Services

-

-

Industrials

-

0.4%

Real Estate

-

-

Utilities

-

-

Healthcare

EKG
94.9%
IDNA
97.8%

Technology

EKG
2.6%
IDNA

-

Basic Materials

EKG

-

IDNA

-

Communication Services

EKG

-

IDNA

-

Consumer Cyclical

EKG

-

IDNA

-

Consumer Defensive

EKG

-

IDNA

-

Energy

EKG

-

IDNA

-

Financial Services

EKG

-

IDNA

-

Industrials

EKG

-

IDNA
0.4%

Real Estate

EKG

-

IDNA

-

Utilities

EKG

-

IDNA

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

EKG vs. IDNA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

EKG
EKG Risk / Return Rank: 88
Overall Rank
EKG Sharpe Ratio Rank: 88
Sharpe Ratio Rank
EKG Sortino Ratio Rank: 88
Sortino Ratio Rank
EKG Omega Ratio Rank: 88
Omega Ratio Rank
EKG Calmar Ratio Rank: 88
Calmar Ratio Rank
EKG Martin Ratio Rank: 88
Martin Ratio Rank

IDNA
IDNA Risk / Return Rank: 5555
Overall Rank
IDNA Sharpe Ratio Rank: 4848
Sharpe Ratio Rank
IDNA Sortino Ratio Rank: 4949
Sortino Ratio Rank
IDNA Omega Ratio Rank: 4242
Omega Ratio Rank
IDNA Calmar Ratio Rank: 7676
Calmar Ratio Rank
IDNA Martin Ratio Rank: 6161
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

EKG vs. IDNA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for First Trust Nasdaq Lux Digital Health Solutions ETF (EKG) and iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


EKGIDNADifference
Sharpe ratioReturn per unit of total volatility

-1.72

Sortino ratioReturn per unit of downside risk

-2.35

Omega ratioGain probability vs. loss probability

1.01

1.27

-0.26

Calmar ratioReturn relative to maximum drawdown

-0.04

3.85

-3.89

Martin ratioReturn relative to average drawdown

-0.10

10.98

-11.07

EKG vs. IDNA - Sharpe Ratio Comparison

The current EKG Sharpe Ratio is -0.04, which is lower than the IDNA Sharpe Ratio of 1.68. The chart below compares the historical Sharpe Ratios of EKG and IDNA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


EKGIDNADifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.04

1.68

-1.72

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.30

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.13

0.10

-0.23

Drawdowns

EKG vs. IDNA - Drawdown Comparison

The maximum EKG drawdown since its inception was -43.82%, smaller than the maximum IDNA drawdown of -68.26%. Use the drawdown chart below to compare losses from any high point for EKG and IDNA.


Loading charts...

Drawdown Indicators


EKGIDNADifference

Max Drawdown

Largest peak-to-trough decline

-43.82%

-68.26%

+24.44%

Max Drawdown (1Y)

Largest decline over 1 year

-22.09%

-10.66%

-11.43%

Max Drawdown (3Y)

Largest decline over 3 years

-34.49%

-29.73%

-4.76%

Max Drawdown (5Y)

Largest decline over 5 years

-68.26%

Current Drawdown

Current decline from peak

-20.78%

-45.61%

+24.83%

Average Drawdown

Average peak-to-trough decline

-22.66%

-36.24%

+13.58%

Ulcer Index

Depth and duration of drawdowns from previous peaks

9.73%

3.73%

+6.00%

Volatility

EKG vs. IDNA - Volatility Comparison

First Trust Nasdaq Lux Digital Health Solutions ETF (EKG) and iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) have volatilities of 7.09% and 7.18%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


EKGIDNADifference

Volatility (1M)

Calculated over the trailing 1-month period

7.09%

7.18%

-0.09%

Volatility (6M)

Calculated over the trailing 6-month period

16.42%

17.98%

-1.56%

Volatility (1Y)

Calculated over the trailing 1-year period

21.57%

24.48%

-2.91%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

27.07%

28.42%

-1.35%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

27.07%

29.53%

-2.46%

EKG vs. IDNA - Expense Ratio Comparison

EKG has a 0.65% expense ratio, which is higher than IDNA's 0.47% expense ratio.


Dividends

EKG vs. IDNA - Dividend Comparison

EKG has not paid dividends to shareholders, while IDNA's dividend yield for the trailing twelve months is around 1.07%.


PositionTTM2025202420232022202120202019
EKG
First Trust Nasdaq Lux Digital Health Solutions ETF
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
IDNA
iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund
1.07%1.18%0.98%1.04%0.54%0.70%0.26%0.80%

Frequently Asked Questions


EKG and IDNA have a correlation of 0.58, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

IDNA has higher volatility (7.18%) compared to EKG (7.09%). In terms of maximum drawdown, EKG dropped -43.82% vs IDNA's -68.26%.

On 3-year performance, IDNA leads with 6.74% vs -0.66% for EKG. On fees, IDNA is cheaper at 0.47% per year. Their volatility is very similar. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 3-year period, IDNA has performed better with a 6.74% return vs -0.66%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

IDNA is cheaper with a 0.47% expense ratio, compared with 0.65% for EKG.

IDNA has the higher dividend yield at 1.07%, compared with 0.00% for EKG.

EKG tracks NASDAQ Lux Health Tech Index, while IDNA tracks NYSE FactSet Global Genomics and Immuno Biopharma Index. They also come from different issuers: First Trust and iShares. Their fees differ too: 0.65% for EKG and 0.47% for IDNA.

IDNA currently has the higher Sharpe Ratio (1.68 vs -0.04), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for EKG and IDNA

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer